1 Min Read
Nov 8 (Reuters) - Biosyent Inc
* BioSyent says unit, BioSyent pharma international signed exclusive license, supply agreement with European partner for new women’s health product Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.